Skip to main content
Constance Mobley, MD, General Surgery, Houston, TX

ConstanceMarieMobleyMDPhD, FACS

General Surgery Houston, TX

Hepatobiliary Surgery, Transplantation, Trauma Surgery & Surgical Critical Care

Associate Professor Surgery, Weill-Cornell Medical College, Houston Methodist Hospital

Dr. Mobley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mobley's full profile

Already have an account?

  • Office

    6445 Main St
    # Opc
    Houston, TX 77030
    Phone+1 713-441-5451
    Fax+1 713-791-5277

Education & Training

  • University of Michigan
    University of MichiganFellowship, Surgical Critical Care, 2010 - 2011
  • University of Michigan
    University of MichiganResidency, Surgery, 2003 - 2010
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2003
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Transplant Hepatology

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2014 - 2025
  • CA State Medical License
    CA State Medical License 2011 - 2024
  • MI State Medical License
    MI State Medical License 2009 - 2019
  • Surgery
    American Board of Surgery Surgery
  • Surgical Critical Care
    American Board of Surgery Surgical Critical Care

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Data and Safety Monitoring Board Approves LyGenesis's Phase 2a Clinical Trial to Continue and Dose Escalate in Novel Trial of Organ Regeneration
    Data and Safety Monitoring Board Approves LyGenesis's Phase 2a Clinical Trial to Continue and Dose Escalate in Novel Trial of Organ RegenerationMarch 4th, 2025

Professional Memberships